1
|
Pineda-Sierra JS, Cifuentes-González C, Rojas-Carabali W, Muñoz-Vargas PT, Henao-Posada A, de-la-Torre A. Clinical characterization of patients with HLA-B27-associated uveitis and evaluation of the impact of systemic treatment on the recurrence rate: a cross-sectional study. J Ophthalmic Inflamm Infect 2023; 13:38. [PMID: 37646883 PMCID: PMC10468442 DOI: 10.1186/s12348-023-00352-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 05/27/2023] [Indexed: 09/01/2023] Open
Abstract
INTRODUCTION Despite HLA-B27-associated uveitis is one of the most frequent etiologies of uveitis worldwide, there are scarce studies on the clinical spectrum of this disease and the implications of therapeutic strategies used in the Latin-American population, with none conducted in Colombia. Thus, this study aimed to describe the clinical characteristics of a cohort of patients with positive HLA-B27-associated uveitis in Colombia and evaluate the impact of systemic treatment on the recurrence rate. METHODS We retrospectively reviewed 490 clinical charts of patients with uveitis, searching for those with positive HLA-B27-associated uveitis over eight years in a referral center in Bogotá, Colombia. We used descriptive statistics to summarize demographic and clinical characteristics and conducted a Chi-square test, Fisher Exact test, Spearman correlation, and Mann-Whitney test to assess associations between treatment strategies and the recurrences rate. RESULTS We analyzed 39 patients (59% females) with positive HLA-B27-associated uveitis, with a median age at the first consultation of 44.5 years (Range: 2-80) and a mean follow-up time of 86.4 weeks (1.65 years). Most patients had unilateral uveitis (53.8%) and an anterior anatomical diagnosis (76.6%); two had anterior chamber fibrinous reaction, and only one had hypopyon. Most patients did not show associated systemic symptoms (66.7%). Topical corticosteroids, NSAIDs, methotrexate, mydriatics, and adalimumab were the most used treatments. The most common complications included cataracts, posterior synechiae, and macular edema. We identified that the rate of recurrences decreases over time (r = -0.6361, P = 0.002571), and this decrease seems to be associated with the initiation of disease-modifying antirheumatic drugs (DMARDs) in chronic and recurrent cases. CONCLUSION The clinical spectrum of HLA-B27-associated uveitis in Colombian patients is distinct from other latitudes. Notably, we found a female predominance, older age at presentation, higher frequency of bilateral and vitreous involvement, and lower frequency of concomitant systemic diseases. Additionally, our results suggest that DMARDs such as methotrexate and biologic agents are good therapeutic options to avoid recurrences in chronic and recurrent cases.
Collapse
Affiliation(s)
- Juan Sebastián Pineda-Sierra
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
- Ophthalmology Interest Group, Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
| | - Carlos Cifuentes-González
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
| | - William Rojas-Carabali
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
| | - Paula Tatiana Muñoz-Vargas
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
| | - Alejandro Henao-Posada
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia
| | - Alejandra de-la-Torre
- Neuroscience (NEUROS) Research Group, Institute of Translational Medicine (IMT), Neurovitae Research Center, Escuela de Medicina Y Ciencias de La Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia.
| |
Collapse
|
3
|
O'Rourke M, Haroon M, Alfarasy S, Ramasamy P, FitzGerald O, Murphy CC. The Effect of Anterior Uveitis and Previously Undiagnosed Spondyloarthritis: Results from the DUET Cohort. J Rheumatol 2017; 44:1347-1354. [PMID: 28668811 DOI: 10.3899/jrheum.170115] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/28/2017] [Indexed: 01/03/2023]
Abstract
OBJECTIVE Anterior uveitis (AU) is an intraocular inflammatory condition closely linked to spondyloarthritis (SpA). Clinical disease variables may often underestimate the true effect of the disease on patient's quality of life. This study examines AU and associated undiagnosed SpA using established quality-of-life tools to inform clinicians of the effect of these diseases. METHODS The Dublin Uveitis Evaluation Tool (DUET) algorithm was developed and validated in a cohort of consecutive patients with AU who were all screened by a rheumatologist for the presence of SpA. This same cohort completed vision-related [Vision Core Measure 1 (VCM1)] and general health [Medical Outcomes Study Short Form-36 (SF-36)] questionnaires when AU was active and resolved. RESULTS VCM1 scores improved with AU resolution. VCM1 did not correlate with vision at baseline, but did on resolution of inflammation. Physical SF-36 scores were reduced during AU episodes and improved on resolution remaining below those of population norms. Subanalysis revealed that SpA scores were more affected than the idiopathic AU group. CONCLUSION AU affects physical aspects of quality of life more than is appreciated by clinical variables, especially in those with pre-existing, undiagnosed SpA. This study is unique in examining the effect of SpA on patients prior to diagnosis. These results highlight the role of the ophthalmologist in identifying patients with SpA who present with AU using the DUET algorithm.
Collapse
Affiliation(s)
- Michael O'Rourke
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland. .,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital.
| | - Muhammad Haroon
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital
| | - Salman Alfarasy
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital
| | - Pathma Ramasamy
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital
| | - Oliver FitzGerald
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital
| | - Conor C Murphy
- From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.,M. O'Rourke, MB, MRCSI (Ophth), FEBO, PhD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; M. Haroon, MB, MRCPI, MMedSc, PhD, Consultant Rheumatologist, University Hospital Kerry; S. Alfaresy, MB, Ophthalmology Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; P. Ramasamy, MB, MRCSI (Ophth), MD, Higher Surgical Trainee, Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; O. FitzGerald, MB, MRCPI, MRCP, FRCPI, MD, Professor of Rheumatology (University College, Dublin), Department of Rheumatology, St Vincent's University Hospital; C.C. Murphy, MB, MMedSc, FRCSI, FRCOphth ( UK), PhD, Professor of Ophthalmology (Royal College of Surgeons in Ireland), Department of Ophthalmology, Royal Victoria Eye and Ear Hospital
| |
Collapse
|